Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

66455 1511539639HCLSTunisiaNovember2017.pdf
Energy Boardroom

Sun Pharma plant feels the heat of FDA import ban

13.03.2014 / Fierce Pharma

A Sun Pharma plant has joined the growing ranks of Indian operations banned by the FDA for manufacturing issues. Unlike Ranbaxy Laboratories and Wockhardt, two other Indian generics players that have recently felt the sting of import alerts, the Sun Pharma plant is not key to its financial success.

LATEST ISSUE

DOWNLOAD

Most Read

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: